Cellular Biomedicine - 49 Year Dividend History | CBMG
Historical dividend payout and yield for Cellular Biomedicine (CBMG) since 1971. The current TTM dividend payout for Cellular Biomedicine (CBMG) as of February 21, 2020 is $0.00. The current dividend yield for Cellular Biomedicine as of February 21, 2020 is 0.00%.
||Medical - Biomedical and Genetics
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.